Constructed Tumor-Targeted and MMP-2 Biocleavable Antibody Conjugated Silica Nanoparticles for Efficient Cancer Therapy

[Image: see text] Antibody–drug conjugates (ADC) are an inevitable trend in the development of modern “precision medicine”. The goal of this work is to produce enzyme-responsive antibody nanoparticle-loaded medication (FMSN-Dox-H2-AE01) based on the EGFR antibody (AE01) and human serum albumin (HSA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao, Ding, Xuefeng, Chen, Yun, Cai, Yanfei, Yang, Zhaoqi, Jin, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099448/
https://www.ncbi.nlm.nih.gov/pubmed/37065049
http://dx.doi.org/10.1021/acsomega.2c07949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099448/
https://www.ncbi.nlm.nih.gov/pubmed/37065049
http://dx.doi.org/10.1021/acsomega.2c07949

Ejemplares similares